According to FarsideInvestors monitoring, the US spot bitcoin ETF had a net outflow of 121.73 million dollars yesterday.
Hengrui Pharmaceutical (01276.HK) rose more than 14% in midday trading, and the company's SHR-2173 injection was approved for clinical use.
Hengrui Pharmaceutical (01276.HK) rose more than 18% intraday, the share price exceeded 70 Hong Kong dollars, a record high, the company SHR-2173 injection was approved for clinical, as of now, SHR-2173 injection related projects accumulated research and development investment of about 64.07 million yuan.
恒瑞医药(01276.HK)盘中涨超18%,股价突破70港元,创历史新高,公司SHR-2173注射液获批临床,截至目前,SHR-2173 注射液相关项目累计研发投入约6,407万元。